Why is phosphonodifluoromethyl phenylalanine a more potent inhibitory moiety than phosphonomethyl phenylalanine toward protein-tyrosine phosphatases?

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  1995-11-22

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1006/BBRC.1995.2716PMID 7488220
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structural basis for phosphotyrosine peptide recognition by protein tyrosine phosphatase 1B.

  1995cited by this paper
• Insulin Receptor Signaling Is Augmented by Antisense Inhibition of the Protein Tyrosine Phosphatase LAR (*)

  1995cited by this paper
• Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling.

  1995cited by this paper
• Osmotic Loading of Neutralizing Antibodies Demonstrates a Role for Protein-tyrosine Phosphatase 1B in Negative Regulation of the Insulin Action Pathway (*)

  1995cited by this paper
• Kinetic and mechanistic characterization of a mammalian protein- tyrosine phosphatase, PTP1

  1995cited by this paper
• Protein-tyrosine phosphatase inhibition by a peptide containing the phosphotyrosyl mimetic, L-O-malonyltyrosine.

  1995cited by this paper
• Selective Down-regulation of the Insulin Receptor Signal by Protein-tyrosine Phosphatases α and ε (*)

  1995cited by this paper
• Dissecting the catalytic mechanism of protein-tyrosine phosphatases.

  1994cited by this paper
• A synthetic tris-sulfotyrosyl dodecapeptide analogue of the insulin receptor 1146-kinase domain inhibits tyrosine dephosphorylation of the insulin receptor in situ.

  1994cited by this paper
• Potent inhibition of insulin receptor dephosphorylation by a hexamer peptide containing the phosphotyrosyl mimetic F2Pmp.

  1994cited by this paper
• Crystal structure of human protein tyrosine phosphatase 1B.

  1994cited by this paper
• Protein tyrosine phosphatase substrate specificity: size and phosphotyrosine positioning requirements in peptide substrates.

  1994cited by this paper
• Nonhydrolyzable phosphotyrosyl mimetics for the preparation of phosphatase-resistant SH2 domain inhibitors.

  1994cited by this paper
• Phosphorylation of receptor protein‐tyrosine phosphatase alpha on Tyr789, a binding site for the SH3‐SH2‐SH3 adaptor protein GRB‐2 in vivo.

  1994cited by this paper
• Specificity of T-cell protein tyrosine phosphatase toward phosphorylated synthetic peptides.

  1993cited by this paper
• Receptor protein tyrosine phosphatase alpha activates pp60c‐src and is involved in neuronal differentiation.

  1993cited by this paper
• A continuous spectrophotometric and fluorimetric assay for protein tyrosine phosphatase using phosphotyrosine-containing peptides.

  1993cited by this paper
• Substrate specificity of the protein tyrosine phosphatases.

  1993cited by this paper
• Binding of a high affinity phosphotyrosyl peptide to the Src SH2 domain: crystal structures of the complexed and peptide-free forms.

  1993cited by this paper
• Inhibition of SH2 domain/phosphoprotein association by a nonhydrolyzable phosphonopeptide.

  1992cited by this paper
• 1002 protein phosphatases?

  1992cited by this paper
• Cell transformation and activation of pp60c-src by overexpression of a protein tyrosine phosphatase

  1992cited by this paper
• Continuous spectrophotometric assay of protein tyrosine phosphatase using phosphotyrosine.

  1992cited by this paper
• Molecular themes in oncogenesis.

  1991cited by this paper
• Cloning, bacterial expression, purification, and characterization of the cytoplasmic domain of rat LAR, a receptor-like protein tyrosine phosphatase.

  1991cited by this paper
• Oncogenes and signal transduction.

  1991cited by this paper
• Evidence for protein-tyrosine-phosphatase catalysis proceeding via a cysteine-phosphate intermediate.

  1991cited by this paper
• Eukaryotic proteins expressed in Escherichia coli: an improved thrombin cleavage and purification procedure of fusion proteins with glutathione S-transferase.

  1991cited by this paper
• Cloning and expression of a protein-tyrosine-phosphatase.

  1990cited by this paper
• Purification and characterization of a low-molecular-weight acid phosphatase--a phosphotyrosyl-protein phosphatase from bovine heart.

  1990cited by this paper
• A new member of the immunoglobulin superfamily that has a cytoplasmic region homologous to the leukocyte common antigen

  1988cited by this paper

• Genetische Codierung von Pentafluorphosphato‐Phenylalanin ermöglicht die Herstellung von PF 5 ‐Proteinen als Phosphoprotein‐Mimetika

  2025cites this paper
• Fragment Screening Identifies Novel Allosteric Binders and Binding Sites in the VHR (DUSP3) Phosphatase

  2025cites this paper
• Genetic Encoding of Pentafluorophosphato‐Phenylalanine Provides PF5‐Proteins as Phosphoprotein Mimetics

  2025cites this paper
• Synthetic trap‐peptides identify a TOM complex phosphatase – PP2A dephosphorylates Tom6

  2025cites this paper
• Genetic Encoding of Phosphorylated Amino Acids into Proteins.

  2024cites this paper
• Recent Advances on the Synthesis and Application of α,α-Difluoro-β-aminophosphonates

  2024cites this paper
• Development of Novel Phosphonodifluoromethyl-Containing Phosphotyrosine Mimetics and a First-In-Class, Potent, Selective, and Bioavailable Inhibitor of Human CDC14 Phosphatases.

  2024cites this paper
• Activity-based tyrosine phosphatomics using F2Pmp probes

  2023cites this paper
• Tinker, Tailor, Soldier, Spy: The Diverse Roles That Fluorine Can Play within Amino Acid Side Chains

  2023cites this paper
• Peptide probes containing a non‐hydrolyzable phosphotyrosine‐mimetic residue for enrichment of protein tyrosine phosphatases

  2021cites this paper
• Therapeutic Targeting of Protein Tyrosine Phosphatases from Mycobacterium tuberculosis

  2020cites this paper
• Asymmetric Synthesis of Chiral Amino Carboxylic‐Phosphonic Acid Derivatives

  2020cites this paper
• Development of Biologically Active Compounds on the Basis of Phosphonic and Phosphinic Acid Functionalities.

  2017cites this paper
• Cell-permeable bicyclic peptidyl inhibitors against T-cell protein tyrosine phosphatase from a combinatorial library.

  2017cites this paper
• Covalent inhibition of protein tyrosine phosphatases.

  2017cites this paper
• Drugging the Undruggable: Therapeutic Potential of Targeting Protein Tyrosine Phosphatases.

  2017cites this paper
• Evaluation of inhibition of protein tyrosine phosphatase 1B by calixarene-based α-ketophosphonic acids

  2015cites this paper
• Bidentate Inhibitors of Protein Tyrosine Phosphatases

  2014cites this paper
• Peptidomimetics as potent and selective PTP1B inhibitors.

  2013cites this paper
• Pharmaceuticals and Other Biomedical Applications

  2013cites this paper
• Rational design of selective organoruthenium inhibitors of protein tyrosine phosphatase 1B.

  2012cites this paper
• Yersinia pestis and approaches to targeting its outer protein H protein-tyrosine phosphatase (YopH).

  2012cites this paper
• Synthesis of 1-deoxy-D-xylulose 5-phosphate reductoisomerase inhibitors as antimalarials

  2012cites this paper
• Discovery of potent, selective and orally bioavailable triaryl-sulfonamide based PTP1B inhibitors.

  2012cites this paper
• A highly selective and potent PTP-MEG2 inhibitor with therapeutic potential for type 2 diabetes.

  2012cites this paper
• Bicyclic benzofuran and indole-based salicylic acids as protein tyrosine phosphatase inhibitors.

  2012cites this paper
• Room-temperature alternative to the Arbuzov reaction: the reductive deoxygenation of acyl phosphonates.

  2010cites this paper
• Peptidomimetic competitive inhibitors of protein tyrosine phosphatases.

  2010cites this paper
• Acquisition of a potent and selective TC-PTP inhibitor via a stepwise fluorophore-tagged combinatorial synthesis and screening strategy.

  2009cites this paper
• Autotaxin structure-activity relationships revealed through lysophosphatidylcholine analogs.

  2009cites this paper
• Reversible and Mechanism-Based Irreversible Inhibitor Studies on Human Steroid Sulfatase and Protein Tyrosine Phosphatase 1B

  2009cites this paper
• Chapter 1 Protein Phosphorylation by Semisynthesis

  2009cites this paper
• Drug discovery and protein tyrosine phosphatases.

  2009cites this paper
• Use of protein tyrosine phosphatase inhibitors as promising targeted therapeutic drugs.

  2009cites this paper
• Protein phosphorylation by semisynthesis: from paper to practice.

  2009cites this paper
• Asymmetric synthesis of β,β-difluoroamino acids via cross-coupling and Strecker reactions

  2008cites this paper
• Use of Fluorinated Functionality in Enzyme Inhibitor Development: Mechanistic and Analytical Advantages.

  2008cites this paper
• Organophosphorus compounds: intervention in mechanisms of signal transduction relevant to proliferative, immunological and circulatory disorders.

  2008cites this paper
• A re-examination of the difluoromethylenesulfonic acid group as a phosphotyrosine mimic for PTP1B inhibition.

  2008cites this paper
• Analyzing the catalytic mechanism of MPtpA: A low molecular weight protein tyrosine phosphatase from Mycobacterium tuberculosis through site‐directed mutagenesis

  2008cites this paper
• A highly efficient route to enantiomerically pure l-N-Bz-Pmp(t-Bu)2-OH and incorporation into a peptide-based protein tyrosine phosphatase inhibitor.

  2008cites this paper
• Synthesis and cell-based activity of a potent and selective protein tyrosine phosphatase 1B inhibitor prodrug.

  2007cites this paper
• Synthesis of Phosphopeptides in the Fmoc Mode

  2007cites this paper
• Photochemical generation of difluoromethyl radicals having various functional groups and their highly regioselective addition to olefins and aromatic substitution

  2007cites this paper
• The Wip1 phosphatase PPM1D dephosphorylates SQ/TQ motifs in checkpoint substrates phosphorylated by PI3K-like kinases.

  2007cites this paper
• Targeting protein tyrosine phosphatase to enhance insulin action for the potential treatment of diabetes.

  2007cites this paper
• Design and synthesis of phosphonodifluoromethyl phenylalanine (F2Pmp): a useful phosphotyrosyl mimetic.

  2006cites this paper
• Enantioselective synthesis of protected L-4-[sulfonamido(difluoromethyl)]phenylalanine and L-4-[sulfonamido(methyl)]phenylalanine and an examination of hexa- and tripeptide platforms for evaluating pTyr mimics for PTP1B inhibition.

  2006cites this paper
• Targeting the PTPome in human disease

  2006cites this paper
• Protein tyrosine phosphatases, new targets for cancer therapy.

  2006cites this paper
• Natural compounds as a source of protein tyrosine phosphatase inhibitors: application to the rational design of small-molecule derivatives.

  2006cites this paper
• Photochemical substitution of olefins and aromatic compounds with difluoromethyl radicals bearing ester and phosphonate groups

  2006cites this paper
• Residues Distant from the Active Site Influence Protein-tyrosine Phosphatase 1B Inhibitor Binding*

  2006cites this paper
• Development of a substrate-based cyclic phosphopeptide inhibitor of protein phosphatase 2Cdelta, Wip1.

  2006cites this paper
• Diastereoselective addition of diethyl difluoromethylphosphonate to enantiopure sulfinimines: synthesis of α,α-difluoro-β-aminophosphonates, phosphonic acids, and phosphonamidic acids

  2006cites this paper
• Highly enantioselective fluorination reactions of β-ketoesters and β-ketophosphonates catalyzed by chiral palladium complexes

  2006cites this paper
• Fluorinated phosphonates: synthesis and biomedical application.

  2006cites this paper
• Structural Insights into the Design of Nonpeptidic Isothiazolidinone-containing Inhibitors of Protein-tyrosine Phosphatase 1B*

  2006cites this paper
• Electrolytic partial fluorination of organic compounds 84: Anodic mono- and difluorination of benzylphosphonate derivatives

  2006cites this paper
• An efficient catalytic enantioselective fluorination of β-ketophosphonates using chiral palladium complexes

  2005cites this paper
• Inhibitors of protein tyrosine phosphatases: next-generation drugs?

  2005cites this paper
• Applying the SPOT peptide synthesis procedure to the study of protein tyrosine phosphatase substrate specificity: probing for the heavenly match in vitro.

  2005cites this paper
• Enantioselective chlorination and fluorination of beta-keto phosphonates catalyzed by chiral Lewis acids.

  2005cites this paper
• Unexpected relative aqueous solubilities of a phosphotyrosine analogue and two phosphonate derivatives.

  2005cites this paper
• Novel alpha,alpha-difluorohomophthalimides via copper-catalyzed tandom cross-coupling-cyclization of 2-halobenzamides with alpha,alpha-difluoro Reformatskii reagent.

  2005cites this paper
• Small molecule approach to studying protein tyrosine phosphatase.

  2005cites this paper
• Cellular Stability of Serotonin N-Acetyltransferase Conferred by Phosphonodifluoromethylene Alanine (Pfa) Substitution for Ser-205*

  2005cites this paper
• Inhibitoren der Proteintyrosinphosphatasen: Kandidaten für zukünftige Wirkstoffe?

  2005cites this paper
• Structure-Based Design of Protein Tyrosine Phosphatase Inhibitors

  2005cites this paper
• Proteinbasierte 3D QSAR-Analysen und virtuelles Screening an Inhibitoren der Protein-Tyrosin-Phosphatase 1B

  2005cites this paper
• Inhibition of protein tyrosine phosphatase 1B as a potential treatment of diabetes and obesity.

  2004cites this paper
• Recent advances in protein tyrosine phosphatase 1B inhibitors

  2004cites this paper
• A nonhydrolyzable analogue of phosphotyrosine, and related aryloxymethano- and aryloxyethano-phosphonic acids as motifs for inhibition of phosphatases.

  2004cites this paper
• The difluoromethylene group as a replacement for the labile oxygen in steroid sulfates: a new approach to steroid sulfatase inhibitors.

  2004cites this paper
• Enantioselective Synthesis of (S)‐3‐Carboxy‐4‐((carboxy)difluoromethyl)phenylalanine in Protected Form and Its Incorporation into a PTP‐1B‐Directed Tripeptide

  2004cites this paper
• 2-difluoromethyloestrone 3-O-sulphamate, a highly potent steroid sulphatase inhibitor.

  2004cites this paper
• Synthesis of fluorine-containing bioisosteres corresponding to phosphoamino acids and dipeptide units.

  2004cites this paper
• Synthesis of non-competitive inhibitors of sphingomyelinases with significant activity.

  2003cites this paper
• Site-specific incorporation of synthetic amino acids into functioning ion channels

  2003cites this paper
• CHAPTER 112 – Inhibitors of Protein Tyrosine Phosphatases

  2003cites this paper
• Crystal Structure of PTP1B Complexed with a Potent and Selective Bidentate Inhibitor*

  2003cites this paper
• Protein tyrosine phosphatase 1B inhibition: opportunities and challenges.

  2003cites this paper
• Inhibitors of protein tyrosine phosphatase 1B (PTP1B).

  2003cites this paper
• A comparison of phosphonothioic acids with phosphonic acids as phosphatase inhibitors.

  2003cites this paper
• Structure-based design and discovery of novel inhibitors of protein tyrosine phosphatases.

  2003cites this paper
• Phosphotyrosyl mimetics in the development of signal transduction inhibitors.

  2003cites this paper
• Protein tyrosine phosphatases: structure and function, substrate specificity, and inhibitor development.

  2002cites this paper
• Molecular modeling of protein tyrosine phosphatase 1B (PTP 1B) inhibitors.

  2002cites this paper
• Design and characterization of an improved protein tyrosine phosphatase substrate-trapping mutant.

  2002cites this paper
• Recent advances in the development of small molecule inhibitors of PTP1B for the treatment of insulin resistance and type 2 diabetes.

  2002cites this paper
• Probing the phosphopeptide specificities of protein tyrosine phosphatases, SH2 and PTB domains with combinatorial library methods.

  2002cites this paper
• Structural basis for inhibition of protein tyrosine phosphatases by Keggin compounds phosphomolybdate and phosphotungstate

  2002influential citation
• The difluoromethylenesulfonic acid group as a monoanionic phosphate surrogate for obtaining PTP1B inhibitors.

  2002cites this paper
• Recent discovery and development of protein tyrosine phosphatase inhibitors

  2002cites this paper
• Synthesis and evaluation of a difluoromethylene analogue of sphingomyelin as an inhibitor of sphingomyelinase.

  2001cites this paper
• (α-Monofluoroalkyl)phosphonates: a class of isoacidic and “tunable” mimics of biological phosphates

  2001cites this paper
• A convergent triflate displacement approach to (alpha-monofluoroalkyl)phosphonates.

  2001cites this paper
• Potent reversible inhibitors of the protein tyrosine phosphatase CD45.

  2001cites this paper
• Acquisition of a Specific and Potent PTP1B Inhibitor from a Novel Combinatorial Library and Screening Procedure*

  2001cites this paper
• Structure of protein tyrosine phosphatase 1B in complex with inhibitors bearing two phosphotyrosine mimetics.

  2001cites this paper